SCHEMBL1746784

SCHEMBL1746784

OCc1cccc2nc(C(F)(F)F)cc(Cl)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 2/20 0.43
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
MAPK1 P28482 1/20 0.40
IGF1R P08069 4/20 0.40
TLR7 Q9NYK1 1/20 0.39
NPSR1 Q6W5P4 3/20 0.39
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
FABP4 P15090 1/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
ADRB2 P07550 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31265529 0.77 ADORA2A (0.56) NT5EADORA2AADORA1MAPK1IGF1R
SCHEMBL10505030 0.77 NT5E (0.47) NT5EADORA2AADORA1IGF1RTLR7
SCHEMBL3618520 0.77 ADORA2A (0.56) NT5EADORA2AADORA1MAPK1IGF1R
SCHEMBL11828023 0.76 NT5E (0.43) NT5EADORA2AADORA1IGF1RNPSR1
SCHEMBL29029750 0.76 ELANE (0.49) NT5EADORA2AADORA1IGF1RTLR7
Hydrochloric Acid SCHEMBL3461991 0.76 ADORA2A (0.55) NT5EADORA2AADORA1MAPK1IGF1R
SCHEMBL11829205 0.73 NT5E (0.50) NT5EADORA2AADORA1IGF1RTLR7
SCHEMBL11831553 0.73 NT5E (0.43) NT5EADORA2AADORA1IGF1RTLR7
SCHEMBL9493205 0.73 NT5E (0.43) NT5EADORA2AADORA1IGF1RTLR7
SCHEMBL693661 0.73 NT5E (0.62) NT5EADORA2AADORA1MAPK1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR NT5E 3219/4885ADORA2A 835/4885ADORA1 535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.